The Royal Manchester Children's Hospital is a children's hospital in Oxford Road, Manchester, England. The Royal Manchester Children's Hospital is managed by the Manchester University NHS Foundation Trust.

There are 371 beds in Royal Manchester Children's Hospital.

During the past decade, Royal Manchester Children's Hospital conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 35 clinical trials were completed, i.e. on average, 40.2% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 21 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Manchester Children's Hospital" #1 sponsor was "Children's Cancer and Leukaemia Group" with 21 trials, followed by "Baxalta now part of Shire" with 9 trials sponsored, "Shire" with 7 trials sponsored, "University of Birmingham" with 5 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 5 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Manchester Children's Hospital" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator, "Australian & New Zealand Children's Haematology/Oncology Group" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 2 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator. Other collaborators include 113 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "Royal Manchester Children's Hospital" are "Brain and Central Nervous System Tumors" (8 trials), "Sarcoma" (7 trials), "Hemophilia A" (6 trials), "Unspecified Childhood Solid Tumor, Protocol Specific" (6 trials) and "Cystic Fibrosis" (5 trials). Many other conditions were trialed in "Royal Manchester Children's Hospital" in a lesser frequency.

Most popular intervention types in "Royal Manchester Children's Hospital" are "Drug" (100 trials), "Biological" (36 trials), "Other" (22 trials), "Procedure" (22 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "radiation therapy" (12 trials), "adjuvant therapy" (10 trials), "carboplatin" (10 trials) and "vincristine sulfate" (10 trials). Other intervention names were less common.

The vast majority of trials in "Royal Manchester Children's Hospital" are 130 trials for "All" genders, 19 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 46 active trials in "Royal Manchester Children's Hospital". 1 are not yet recruiting, 28 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 64 completed trials in Royal Manchester Children's Hospital, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Manchester Children's Hospital, 24 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".